Persistence with Prostaglandin Agonist Use with and without Adjunctive Therapy for Glaucoma Patients: A Canadian Population-Based Analysis

Author： Iskedjian Michael  

Publisher： Adis International

ISSN： 1178-1661

Source： The Patient: Patient-Centered Outcomes Research, Vol.4, Iss.2, 2011-06, pp. : 133-141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Estimated first-year costs of prostaglandin analogs with/without adjunctive therapy for glaucoma management: a United States perspective

By Schmier Jordana K.   Covert David W.   Robin Alan L.  

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2867-2875

Informa Healthcare

Access to resources Recommend Favorite

Physicians’ treatment decisions, patient persistence, and interruptions in the continuous use of prostaglandin therapy in glaucoma

By Hahn Steven R.   Kotak Sameer   Tan Jason   Kim Elizabeth  

Current Medical Research and Opinion, Vol. 26, Iss. 4, 2010-04 ,pp. : 957-963

Informa Healthcare

Access to resources Recommend Favorite

Adjunctive traditional Chinese medicine therapy for patients with chronic rhinosinusitis: a population‐based study

By  

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, Vol. 5, Iss. 3, 2015-03 ,pp. : 240-246

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adjunctive traditional Chinese medicine therapy improves survival in patients with advanced breast cancer: A population‐based study

By  

CANCER, Vol. 120, Iss. 9, 2014-05 ,pp. : 1338-1344

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost

By Covert David   Robin Alan L.  

Current Medical Research and Opinion, Vol. 22, Iss. 5, 2006-05 ,pp. : 971-976

Informa Healthcare

Access to resources Recommend Favorite